Discovery of bile salt hydrolase inhibitors using an efficient high-throughput screening system.
The global trend of restricting the use of antibiotic growth promoters (AGP) in animal production necessitates the need to develop valid alternatives to maintain productivity and sustainability of food animals. Previous studies suggest inhibition of bile salt hydrolase (BSH), an intestinal bacteria-produced enzyme that exerts negative impact on host fat digestion and utilization, is a promising approach to promote animal growth performance. To achieve the long term goal of developing novel alternatives to AGPs, in this study, a rapid and convenient high-throughput screening (HTS) system was developed and successfully used for identification of BSH inhibitors. With the aid of a high-purity BSH from a chicken Lactobacillus salivarius strain, we optimized various screening conditions (e.g. BSH concentration, reaction buffer pH, incubation temperature and length, substrate type and concentration) and establish a precipitation-based screening approach to identify BSH inhibitors using 96-well or 384-well microplates. A pilot HTS was performed using a small compound library comprised of 2,240 biologically active and structurally diverse compounds. Among the 107 hits, several promising and potent BSH inhibitors (e.g. riboflavin and phenethyl caffeate) were selected and validated by standard BSH activity assay. Interestingly, the HTS also identified a panel of antibiotics as BSH inhibitor; in particular, various tetracycline antibiotics and roxarsone, the widely used AGP, have been demonstrated to display potent inhibitory effect on BSH. Together, this study developed an efficient HTS system and identified several BSH inhibitors with potential as alternatives to AGP. In addition, the findings from this study also suggest a new mode of action of AGP for promoting animal growth.
Department of Animal Science, University of Tennessee, Knoxville, Tennessee, United States of America.
Katie
K
Smith
Department of Animal Science, University of Tennessee, Knoxville, Tennessee, United States of America.
Ximin
X
Zeng
Department of Animal Science, University of Tennessee, Knoxville, Tennessee, United States of America.
Jun
J
Lin
D000581:Amidohydrolases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000821:Animal Feed / Q000032:analysis; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002645:Chickens / Q000254:growth & development / Q000382:microbiology; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D057075:Enzyme Assays; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D057166:High-Throughput Screening Assays / Q000379:methods*; D007422:Intestines / Q000187:drug effects / Q000201:enzymology; D007778:Lactobacillus / Q000187:drug effects / Q000201:enzymology; D050356:Lipid Metabolism / Q000187:drug effects; D015203:Reproducibility of Results; D013997:Time Factors
D000900:Anti-Bacterial Agents; D004791:Enzyme Inhibitors; D000581:Amidohydrolases; C023154:choloylglycine hydrolase